Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer

Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.

Guardado en:

Detalles Bibliográficos
Autores principales:	Naoki Nishio, Nynke S. van den Berg, Stan van Keulen, Brock A. Martin, Shayan Fakurnejad, Nutte Teraphongphom, Stefania U. Chirita, Nicholas J. Oberhelman, Guolan Lu, Crista E. Horton, Michael J. Kaplan, Vasu Divi, A. Dimitrios Colevas, Eben L. Rosenthal
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2019
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/9d94d112023644caad227f072f22a399
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9d94d112023644caad227f072f22a399
record_format	dspace
spelling	oai:doaj.org-article:9d94d112023644caad227f072f22a3992021-12-02T17:02:10ZOptical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer10.1038/s41467-019-13076-72041-1723https://doaj.org/article/9d94d112023644caad227f072f22a3992019-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-13076-7https://doaj.org/toc/2041-1723Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.Naoki NishioNynke S. van den BergStan van KeulenBrock A. MartinShayan FakurnejadNutte TeraphongphomStefania U. ChiritaNicholas J. OberhelmanGuolan LuCrista E. HortonMichael J. KaplanVasu DiviA. Dimitrios ColevasEben L. RosenthalNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Naoki Nishio Nynke S. van den Berg Stan van Keulen Brock A. Martin Shayan Fakurnejad Nutte Teraphongphom Stefania U. Chirita Nicholas J. Oberhelman Guolan Lu Crista E. Horton Michael J. Kaplan Vasu Divi A. Dimitrios Colevas Eben L. Rosenthal Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
description	Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.
format	article
author	Naoki Nishio Nynke S. van den Berg Stan van Keulen Brock A. Martin Shayan Fakurnejad Nutte Teraphongphom Stefania U. Chirita Nicholas J. Oberhelman Guolan Lu Crista E. Horton Michael J. Kaplan Vasu Divi A. Dimitrios Colevas Eben L. Rosenthal
author_facet	Naoki Nishio Nynke S. van den Berg Stan van Keulen Brock A. Martin Shayan Fakurnejad Nutte Teraphongphom Stefania U. Chirita Nicholas J. Oberhelman Guolan Lu Crista E. Horton Michael J. Kaplan Vasu Divi A. Dimitrios Colevas Eben L. Rosenthal
author_sort	Naoki Nishio
title	Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_short	Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_full	Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_fullStr	Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_full_unstemmed	Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_sort	optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
publisher	Nature Portfolio
publishDate	2019
url	https://doaj.org/article/9d94d112023644caad227f072f22a399
work_keys_str_mv	AT naokinishio opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT nynkesvandenberg opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT stanvankeulen opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT brockamartin opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT shayanfakurnejad opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT nutteteraphongphom opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT stefaniauchirita opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT nicholasjoberhelman opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT guolanlu opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT cristaehorton opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT michaeljkaplan opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT vasudivi opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT adimitrioscolevas opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer AT ebenlrosenthal opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
_version_	1718381985962917888

Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer

Ejemplares similares